Fig. 2From: Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myelomaKaplan-Meier plots for PFS and OS for NDMM patients treated with standard of care ASCT. (A, B) PFS (A) and OS (B) for the entire cohort of 168 patients; (C, D) PFS (C) and OS (D) stratified by the number of HRCA (0 vs. 1 vs. ≥2 HRCA). HRCA, high-risk cytogenetics; PFS, progression free survival; OS, overall survivalBack to article page